Skip to main content

Call for papers - Translating the microbiome in health and disease

Guest Editor
Peggy Lai, MD, MPH, Harvard University, USA

Submission Status: Open   |   Submission Deadline: 1 December 2024

Genome Medicine is calling for submission to a new Collection on translating the microbiome in health and disease, guest edited by Peggy Lai from Harvard University.

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health & Well-Being.

About the collection

Genome Medicine is calling for submission to a new Collection on translating the microbiome in health and disease. 

Over the past two decades progress in the study of the human microbiome has accelerated. Critical to this advancement is the advent of novel technologies which have allowed the interrogation of the complex host-microbiome relationship. These tools, techniques and methods have helped accomplish the phylogenomic characterization of diverse microbiomes, permitted the functional profiling of microbiome data, and have given us a deeper understanding of how the microbiome relates to different disease states and mechanisms. Particularly intriguing is how the analysis of microbiome and multi-omics data can be utilized for clinical benefit and improve patient care.

To capture advances in this growing area, Genome Medicine is pleased to announce a call for papers for our upcoming special collection on ‘Translating the microbiome in health and disease,’ guest edited by Peggy Lai from Harvard University We are particularly interested in encouraging collaboration between basic and clinical researchers. The Guest Editor may be able to provide guidance on fostering such collaborations; please contact the editorial team to discuss further.

We are now inviting the submission of Research, Method, Software, Database and Guideline manuscripts of outstanding interest describing insights into all aspects of the human microbiome in health and disease including:

  • Metagenomics and integrative multi-omics 
  • Microbiome analysis tools and technologies
  • Artificial intelligence approaches
  • Single-cell tools and technologies  
  • Long-read sequencing
  • Healthy microbiome
  • The aging microbiome
  • The maternal microbiome
  • The fetal, preterm and infant microbiome 
  • Trans-ethnic microbiome diversity 
  • Metabolic disorders and the role of diet
  • Microbiome-immune homeostasis and regulation of the immune response
  • Host-microbiome interactions
  • Microbiome-encoded disease phenotypes
  • The cancer and tumor microbiome
  • Microbiome in tumor immunity and therapeutic response 
  • Translational interventions, clinical trials and therapies
  • Infectious disease microbiome
  • Gut-brain axis
  • The human virome
  • The human mycobiome
  • In vivo microbiome construction
  • Microbiome diagnostics
  • FMT dynamics and efficacy 
  • Precision editing/modulation of the microbiome 
  • Translational interventions, clinical trials and therapies

Image credit: Viks_jin /

Meet the Guest Editor

Back to top

Peggy Lai, MD, MPH, Harvard University, USA

Dr Lai is an Associate Professor of Medicine at Harvard Medical School and is a practicing Pulmonary and Critical Care Physician at Massachusetts General Hospital. She attended medical school at Columbia University College of Physicians and Surgeons (P&S) in New York City followed by Pulmonary and Critical Care Fellowship at Massachusetts General Hospital, Brigham and Women’s Hospital, and Beth Israel Deaconess Medical Center in Boston. Her current research portfolio revolves broadly around the use of high-dimensional data in clinical and translational studies to better understand research at the intersection of environmental exposures, the human microbiome, and chronic lung diseases. Recent projects focus on microbial (including viral) exposures in elementary schools and asthma morbidity, the effect of supplemental oxygen on the airway microbiome, and the role of household air pollution exposure on the human microbiome. Her laboratory also focuses on methods development for successful microbiome sequencing of challenge samples including respiratory and built environment samples.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of Research, Method, Software, Database, and Guideline articles. Before submitting your manuscript, please ensure you have read our submission guidelines

Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Translating the microbiome in health and disease" from the dropdown menu.

All articles submitted to Collections are peer reviewed in line with the journal’s standard peer review policy and are subject to all of the journal’s standard editorial and publishing policies. This includes the journal’s policy on competing interests. 

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editor or Editorial Board Member who has no competing interests.